Exela Pharma Sciences LLC

Lenoir, NC Exela Pharma Sciences, LLC

UEI
M6CZR21V9HX9
CAGE
7A4M2
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Other Than One of the Proceeding
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1245 Blowing Rock Blvd, Lenoir, NC 28645, USA
Website
exelapharma.com
Founded
2005
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Exela Pharma Sciences LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Industrial base expansion cooperative agreement to exela pharma sciences, LLC (?exela?) Grant · IDSEP230059 Office of the Assistant Secretary for Preparedness and Response $126,539,046
Covid-19 action. Industrial base expansion cooperative agreement to exela pharma sciences, LLC (exela) Grant · W58P052220009 ACC Aberdeen Proving Ground $40,402,738

About Exela Pharma Sciences LLC

Exela Pharma Sciences LLC, operating through its Exela Pharma Sciences, LLC Division, is a minority-owned, self-certified small disadvantaged business that provides pharmaceutical and medical countermeasure services to the U.S. federal government. Registered in SAM.gov since December 2014, the company is structured as a corporate entity and classified as a for-profit organization. Exela Pharma Sciences specializes in the development, manufacturing, and supply of critical pharmaceuticals and biological products, with a focus on supporting national preparedness and response to public health emergencies.

The company has been awarded significant federal grant funding to expand industrial base capabilities for COVID-19 response and other potential biological threats. In December 2022, Exela received a cooperative agreement from the Office of the Assistant Secretary for Preparedness and Response to support industrial base expansion, with a completion date extending to December 2035. Additionally, in May 2022, the Department of the Army's Joint PEO Chemical and Biological Defense awarded Exela a $40.4 million cooperative agreement under the Research on Chemical and Biological Defense program. This grant, running through May 2034, aims to enhance domestic production capacity for medical countermeasures against COVID-19 and future pandemics. The scope of work includes technology transfer, workforce training, and facility upgrades at Exela's Lenoir, North Carolina location, contributing to the diversification of the industrial base for critical medical supplies.

Exela Pharma Sciences LLC also holds a Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs, specifically for Veterans Integrated Service Network 12. This multiple-award contract (ID: 36F79724D0210) has a ceiling value of $20,304,570.00 and is set to run from September 29, 2024, to September 28, 2029. Under this FSS, Exela is contracted to provide a wide range of drugs, pharmaceuticals, and hematology-related products. This agreement allows the VA to procure essential medical supplies efficiently, supporting its healthcare operations and patient needs within the designated service network. The contract's broad scope indicates Exela's capability to manufacture and supply a diverse portfolio of pharmaceutical products critical to veterans' healthcare services.

Contract vehicles

Quick answers

What is Exela Pharma Sciences LLC's UEI?

Exela Pharma Sciences LLC's Unique Entity ID (UEI) in SAM.gov is M6CZR21V9HX9.

What is Exela Pharma Sciences LLC's CAGE code?

Exela Pharma Sciences LLC's CAGE code is 7A4M2.

What is Exela Pharma Sciences LLC's primary NAICS code?

Exela Pharma Sciences LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Exela Pharma Sciences LLC located?

Exela Pharma Sciences LLC's physical address in SAM.gov is 1245 Blowing Rock Blvd, Lenoir, NC 28645, USA.

Is Exela Pharma Sciences LLC registered in SAM.gov?

Yes. Exela Pharma Sciences LLC's SAM.gov registration is active through November 25, 2026.

Which contract vehicles does Exela Pharma Sciences LLC hold?

Exela Pharma Sciences LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Exela Pharma Sciences LLC's most recent federal award?

Exela Pharma Sciences LLC's most recent federal grant award is Industrial base expansion cooperative agreement to exela pharma sciences, LLC (?exela?) (IDSEP230059), from Office of the Assistant Secretary for Preparedness and Response, on December 15, 2022.

On GovTribe

See Exela Pharma Sciences LLC's full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors